🇺🇸 FDA
Patent

US 9173966

Luciferin derivatives from bicyclic reactants and aminothiol derivatives and methods of use thereof

granted A61KA61K31/427A61K49/0017

Quick answer

US patent 9173966 (Luciferin derivatives from bicyclic reactants and aminothiol derivatives and methods of use thereof) held by The Regents of the University of California expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/427, A61K49/0017, A61K49/0021